Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA to review re-submitted Bristol-Myers hepatitis C drug
FDA to review re-submitted Bristol-Myers hepatitis C drug
FDA to review re-submitted Bristol-Myers hepatitis C drug
Submitted by
admin
on March 12, 2015 - 9:44pm
Source:
Yahoo/Reuters
News Tags:
FDA
Bristol-Myers Squibb
daclatasvir
hepatitis C
Headline:
FDA to review re-submitted Bristol-Myers hepatitis C drug
Do Not Allow Advertisers to Use My Personal information
